Pharmacia Switch Focus Impetus For OTC Operations Changes, Relocation
This article was originally published in The Tan Sheet
Executive Summary
Pharmacia is reorganizing its consumer healthcare operations to focus on Rx-to-OTC switches following the firm's merger with Monsanto and its G.D. Searle unit completed in March. The COX-2 inhibitor celecoxib (Celebrex) is a strong switch candidate, Pharmacia said.